Establishment of model system for hematological disorders associated with mutated signal transduction molecules
Establishment of model system for hematological disorders associated with mutated signal transduction molecules
批准号:
12470204
负责人:
KOMATSU Norio
金额:
$8.96万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2002
中文摘要
点击翻译按钮获取中文摘要
英文摘要
1. The signal transducer and activator of transcription 3 (Stat3), a member of the Stat family of proteins, is commonly activated by thrombopoietic cytokines including thrombopoietin (TPO), interleukin (IL)-6, and interleukin-11. This finding strongly suggested that Stat3 has an important role in megakaryopoiesis and thrombopoiesis. To clarify the functional role of Stat3 in in vivo megakaryopoiesis and thrombopoiesis, we generated transgenic mice overexpressing a dominant-negative Stat3, Stat3F, to suppress the function of endogenous Stat3. To accomplish the selective expression of Stat3F in megakaryocytic lineage cells, we used the regulatory gene region of GATA-1 transcription factor selectively expressed in megakaryocytic and erythroid lineage cells. Two independent transgenic (Tg) mice lines were established. Platelet counts were within the normal range in steady-state conditions and were recovered normally from transient thrombocytopenia induced by antiplatelet serum injection. I … More nterestingly, the platelet recovery from myelosuppression after 5-fluorouracil treatment was significantly delayed in the Tg mice. Collectively, our results strongly suggest that Stat3 plays an important role in the early stage of megakaryopoiesis, presumably through the expansion of megakaryocytic progenitor cells.2. FKHRL1, a member of the Forkhead transcription factor family, is a mammalian homologue of DAF-16 which plays an important role in the longevity of Caenorhabditis elegans. We found that FKHRL1 is one of the downstream molecules of phosphatidylinositol 3-kinase in the erythropoietin (EPO) signaling pathway, and that this molecule is phosphorylated directly by activated Akt, resulting in a loss of transcriptional activity. In addition, FKHRL1 mRNA was detectable in various kinds of hematopoietic cells including CD34+/CD38-, CD34+, glycophorin A+, glycoprotein II/IIIa+, and CD13+ cells. In particular, glycophorin A+ cells strongly expressed FKHRL1 at the mRNA level. To clarify the functional role of FKHRL1 in erythropoiesis, we prepared FKHRL1-TM which is replaced at three Akt phosphorylation sites, Thr32, Ser253, and Ser315 with alanine. Cord blood-derived CD34-positive cells were transduced with the bicistronic retroviral vector expressing FKHRL1-TM and green fluorescent protein (GFP) using an internal ribosome entry site (IRES). The amount of erythroid colony derived from FKHRL1-TM-transduced CD34+ cells was about 40% of that from the control vector-transduced cells. To elucidate the mechanism by which FKHRL1 inhibits erythroid colony formation, we generated a tamoxifen-inducible FKHRL1-TM : ER system in an EPO-dependent cell line, UT-7/EPO. Addition of tamoxifen inhibited the cell cycle growth and cell cycle progression. Our results suggest that FKHRL1 controls the cell cycling of erythroid cells via regulating cell cycle-associated gene expression. Less
期刊论文(108)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Uchida, M: "A functional role of mitogen-activated protein kinase, Erk1 and Erk2, in the differentiation of a human leukemia cell line, UT-7/GM : a possible key factor for cell fate determination toward erythroid and megakaryocytic lineages"Int J Haematol
Uchida, M:“丝裂原激活蛋白激酶 Erk1 和 Erk2 在人类白血病细胞系 UT-7/GM 分化中的功能作用:细胞命运决定向红系和巨核细胞谱系的可能关键因素”Int
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kirito,K: "Constitutive Activation of Statl and StatS in Primary Erithroleukemia Cells"Int.J.Hematol.. 75. 51-54 (2002)
Kirito,K:“原代红白血病细胞中 Stat1 和 StatS 的组成型激活”Int.J.Hematol.. 75. 51-54 (2002)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Otsuki,T: "Phosphorylation of fanconi anemia protein, FANCA, is regulated by Akt kinase"Biochem Biophys Res Commun.. 291. 628-634 (2002)
Otsuki,T:“范可尼贫血蛋白 FANCA 的磷酸化受 Akt 激酶调节”Biochem Biophys Res Commun.. 291. 628-634 (2002)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Mori, M: "Activation of extracellular signal-regulated kinaze ERK1 and ERK2 induces bcl-xl up-regulation via inhibition of caspase activities in erythropietin signaling"J Cell Physiol. (in press).
Mori, M:“细胞外信号调节激酶 ERK1 和 ERK2 的激活通过抑制促红细胞生成素信号传导中的 caspase 活性诱导 bcl-xl 上调”J Cell Physiol。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kirito, K: "TPO regulates Bcl-xL gene expression through Stat5 and phosphatidylinositol-3-kinase activation pathways"J Biol Chem. 277. 8329-8337 (2002)
Kirito, K:“TPO 通过 Stat5 和磷脂酰肌醇 3 激酶激活途径调节 Bcl-xL 基因表达”J Biol Chem。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 40 条
Identification of promising marker(s) for essential thrombocythemia diagnosis by differential gene expression approach
-
批准号:15K15368
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.33万
-
财政年份:2015
-
负责人:KOMATSU Norio
-
依托单位:
Development of novel therapeutic strategy for targeting transcription factors expressed in cancer stem cells
-
批准号:18390282
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.74万
-
财政年份:2006
-
负责人:KOMATSU Norio
-
依托单位:
The development of targeted therapies using FKHRL1 for the treatment of leukemia
-
批准号:15390306
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.41万
-
财政年份:2003
-
负责人:KOMATSU Norio
-
依托单位:
analysis of molecular mechanism of hematopoiesis and hematological disorders
-
批准号:09470233
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.06万
-
财政年份:1997
-
负责人:KOMATSU Norio
-
依托单位:
Characterization of 85Kd protein tyrosine phosphorylated by erythropoietin stimulation
-
批准号:05670926
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.41万
-
财政年份:1993
-
负责人:KOMATSU Norio
-
依托单位:
海外基金